ABSTRACT
Background Polygenic risk scores (PRSs) are increasingly used in psychiatric research to operationalize genetic propensity towards a particular mental disorder. PRSs hold promise as early predictors of psychiatric symptoms in clinical settings, but, before a PRS can be clinically used, their specificity towards a psychiatric domain needs to be evaluated and their explanatory power increased. In this study we tested whether PRSs associate more with general or specific psychopathology in school-aged children. In addition, we tested whether psychiatric PRSs can be combined into a multi-PRS score for improved performance.
Methods We computed 16 PRSs based on GWASs of psychiatric outcomes, but also neuroticism and cognitive ability. Study participants were 9267 school-aged children from three population-based cohorts of the DREAM-BIG consortium: ALSPAC (England), The Generation R Study (the Netherlands) and MAVAN (Canada). We associated each PRS with general and specific psychopathology factors, derived from a bifactor model based on self-, parental-, teacher-, and observer reports. After fitting each PRS in separate models, we also tested a multi-PRS model, in which all PRSs are entered simultaneously as predictors of the general psychopathology factor.
Results Seven PRSs were associated with the general psychopathology factor after multiple testing adjustment, two with specific externalizing and four with specific internalizing psychopathology. PRSs predicted general psychopathology independent of each other, with the exception of depression and depressive symptom PRSs. Each PRS associated with a specific psychopathology domain, was also associated with general child psychopathology.
Conclusions The results suggest that PRSs based on current GWASs of psychiatric outcomes tend to be associated with general psychopathology, or both general and specific psychiatric symptoms, but not with one specific psychopathology domain only. Furthermore, PRSs can be combined to improve predictive ability. PRS users should therefore be conscious of non-specificity and consider using multiple PRS simultaneously, when predicting psychiatric disorders.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
ALSPAC The UK Medical Research Council (MRC) and Wellcome (102215/2/13/2) and the University of Bristol provide core support for ALSPAC. GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. This work was supported by the MRC and the University of Bristol (MC_UU_00011/7). H.M.Sallis is also supported by the European Research Council (758813 MHINT). GenR The Generation R Study is conducted by the Erasmus Medical Center in close collaboration with the Erasmus University Rotterdam, Faculty of Social Sciences, the Municipal Health Service Rotterdam area, and the Stichting Trombosedienst and Artsenlaboratorium Rijnmond. The Generation R Study is financially supported by Erasmus Medical Center and the Netherlands Organization for Health Research and Development. A. Neumann and H. Tiemeier are supported by a grant of the Dutch Ministry of Education, Culture, and Science and the Netherlands Organization for Scientific Research (024.001.003, Consortium on Individual Development). The work of H. Tiemeier is further supported by a European Unions Horizon 2020 research and innovation program (633595, DynaHealth) and a NWO-VICI grant (016.VICI.170.200). MAVAN The MAVAN project was funded by a Canadian Institutes of Health Research (CIHR) trajectory grant (191827). Private support was received from the McGill University Faculty of Medicine, the Norlien Foundation, and the Woco Foundation. This study was made possible by the CHIR (359912, 365309, and 231614), the Fonds de la recherche en sante du Quebec (22418), and the March of Dimes Foundation (12-FY12-198). R. Levitan is supported by the Cameron Parker Holcombe Wilson Chair in Depression Studies, University of Toronto and the Centre for Addiction and Mental Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained by local ethics committees (ALSPAC Ethics and Law Committee, Medical Ethics Committee of the Erasmus Medical Center, Douglas Mental Health University Institute and St-Josephs Hospital).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
To ensure participant privacy and law compliance, individual-level data cannot be made publicly available without explicit informed consent, which is not available. For new analyses or individual-level data access, please contact Generation R data management (datamanagementgenr@erasmusmc.nl) and the corresponding author.
https://generationr.nl/researchers/collaboration/
ABBREVIATIONS
- PRS
- Polygenic Risk Score
- GWAS
- Genome-Wide Association Study
- SNP
- Single Nucleotide Polymorphism
- ADHD
- Attention-Deficit Hyperactivity Disorder
- DREAM-BIG
- Developmental Research in Environmental Adversity, Mental health, Biological susceptibility and Gender
- ALSPAC
- Avon Longitudinal Study of Parents and Children
- GenR
- Generation R
- MAVAN
- Maternal Adversity, Vulnerability and Neurodevelopment